Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
BMC Cancer
|
September 18, 2010
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
Jennifer A Byrne, Sanaz Maleki, Jayne R Hardy, et al.
Plos One
|
February 25, 2012
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients
Francis Jacob, Kristjan Ukegjini, Sheri Nixdorf, et al.
JAMA Network Open
|
March 10, 2026
Cancer Incidence in Women After Medically Assisted Reproduction
Claire Melissa Vajdic, Adrian Raymond Walker, Antoinette C Anazodo, et al.
JAMA Network Open
|
July 13, 2026
Medically Assisted Reproduction and Hormone-Related Cancers
Adrian Raymond Walker, Christos Venetis, Signe Opdahl, et al.
Gynecologic Oncology
|
November 26, 2011
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
Céline Montavon, Brian S Gloss, Kristina Warton, et al.
Journal of Clinical Pathology
|
July 11, 2006
Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries
Viola A Heinzelmann-Schwarz, Richard A Scolyer, James P Scurry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2004
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
Viola A Heinzelmann-Schwarz, Margaret Gardiner-Garden, Susan M Henshall, et al.
Oncotarget
|
November 18, 2015
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
Kim Moran-Jones, Brian S Gloss, Rajmohan Murali, et al.
NPJ Precision Oncology
|
June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Dane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
Oncogene
|
August 7, 2003
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer
Jennifer L Clancy, Michelle J Henderson, Amanda J Russell, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
BMC Cancer
|
September 18, 2010
MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome
Jennifer A Byrne, Sanaz Maleki, Jayne R Hardy, et al.
Plos One
|
February 25, 2012
Loss of secreted frizzled-related protein 4 correlates with an aggressive phenotype and predicts poor outcome in ovarian cancer patients
Francis Jacob, Kristjan Ukegjini, Sheri Nixdorf, et al.
JAMA Network Open
|
March 10, 2026
Cancer Incidence in Women After Medically Assisted Reproduction
Claire Melissa Vajdic, Adrian Raymond Walker, Antoinette C Anazodo, et al.
JAMA Network Open
|
July 13, 2026
Medically Assisted Reproduction and Hormone-Related Cancers
Adrian Raymond Walker, Christos Venetis, Signe Opdahl, et al.
Gynecologic Oncology
|
November 26, 2011
Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
Céline Montavon, Brian S Gloss, Kristina Warton, et al.
Journal of Clinical Pathology
|
July 11, 2006
Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries
Viola A Heinzelmann-Schwarz, Richard A Scolyer, James P Scurry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 9, 2004
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
Viola A Heinzelmann-Schwarz, Margaret Gardiner-Garden, Susan M Henshall, et al.
Oncotarget
|
November 18, 2015
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer
Kim Moran-Jones, Brian S Gloss, Rajmohan Murali, et al.
NPJ Precision Oncology
|
June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
Dane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
Oncogene
|
August 7, 2003
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer
Jennifer L Clancy, Michelle J Henderson, Amanda J Russell, et al.
Page
of 7